SOLV · SOLVENTUM CORP.

Back to holdings

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.

Close · 3M

+34.91%

Held by 0 AI ETFs

None of the tracked AI ETFs currently hold this name.

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals20

Win rate100% (20/20)

Avg buy return+14.44%

AIVLno longer held29 signals

AIVL · Exit · 1d

weight 0.254% → 0 (exited)·stock up 4.5% in the 30 days before

Sep 2·entry $91.90·now $92.44

+0.59%

since Sep 2

AIVL · Accumulation · 5d

weight 0.236% → 0.253% (+0.016 pp)·stock up 17.0% in the 30 days before

Aug 24·entry $91.25·now $92.44Fresh

+1.30%

since Aug 24

AIVL · Accumulation · 5d

weight 0.235% → 0.248% (+0.013 pp)·stock up 16.0% in the 30 days before

Aug 21·entry $89.57·now $92.44Drifting

+3.20%

since Aug 21

AIVL · Accumulation · 5d

weight 0.232% → 0.245% (+0.013 pp)·stock up 14.1% in the 30 days before

Aug 20·entry $88.61·now $92.44Drifting

+4.32%

since Aug 20

AIVL · Accumulation · 5d

weight 0.228% → 0.241% (+0.013 pp)·stock up 10.3% in the 30 days before

Aug 18·entry $87.45·now $92.44Drifting

+5.71%

since Aug 18

AIVL · Weight increase · 3d

weight 0.232% → 0.241% (+0.009 pp)·stock up 8.4% in the 30 days before

Aug 14·entry $88.59·now $92.44Drifting

+4.35%

since Aug 14

AIVL · Weight increase · 2d

weight 0.232% → 0.236% (+0.004 pp)·stock up 10.3% in the 30 days before

Aug 13·entry $86.46·now $92.44Drifting

+6.92%

since Aug 13

AIVL · Weight decrease · 2d

weight 0.245% → 0.228% (-0.017 pp)·stock up 9.2% in the 30 days before

Aug 7·entry $82.98·now $92.44

+11.40%

since Aug 7

AIVL · Weight increase · 2d

weight 0.264% → 0.298% (+0.034 pp)·stock up 13.2% in the 30 days before

Jul 29·entry $88.55·now $92.44Drifting

+4.39%

since Jul 29

AIVL · Weight decrease · 4d

weight 0.276% → 0.263% (-0.013 pp)·stock up 4.4% in the 30 days before

Jul 23·entry $77.24·now $92.44

+19.68%

since Jul 23

AIVL · Weight decrease · 3d

weight 0.276% → 0.265% (-0.011 pp)·stock up 5.5% in the 30 days before

Jul 22·entry $77.64·now $92.44

+19.06%

since Jul 22

AIVL · Weight decrease · 2d

weight 0.276% → 0.268% (-0.007 pp)·stock up 4.2% in the 30 days before

Jul 21·entry $78.60·now $92.44

+17.61%

since Jul 21

AIVL · Weight increase · 2d

weight 0.261% → 0.275% (+0.014 pp)·stock up 6.2% in the 30 days before

Jul 16·entry $81.70·now $92.44Chased

+13.15%

since Jul 16

AIVL · Weight increase · 2d

weight 0.260% → 0.264% (+0.004 pp)·stock down 4.3% in the 30 days before

Jul 13·entry $77.42·now $92.44Chased

+19.40%

since Jul 13

AIVL · Accumulation · 5d

weight 0.253% → 0.265% (+0.012 pp)·stock up 2.4% in the 30 days before

Jul 2·entry $78.27·now $92.44Chased

+18.10%

since Jul 2

AIVL · Accumulation · 5d

weight 0.261% → 0.269% (+0.008 pp)·stock up 3.3% in the 30 days before

Jul 1·entry $78.35·now $92.44Chased

+17.98%

since Jul 1

AIVL · Weight increase · 4d

weight 0.253% → 0.271% (+0.018 pp)·stock up 4.8% in the 30 days before

Jun 26·entry $79.53·now $92.44Chased

+16.23%

since Jun 26

AIVL · Weight increase · 3d

weight 0.253% → 0.265% (+0.013 pp)·stock up 2.2% in the 30 days before

Jun 25·entry $77.92·now $92.44Chased

+18.63%

since Jun 25

AIVL · Weight increase · 2d

weight 0.253% → 0.262% (+0.009 pp)·stock down 1.6% in the 30 days before

Jun 24·entry $75.59·now $92.44Chased

+22.29%

since Jun 24

AIVL · Weight decrease · 5d

weight 0.290% → 0.253% (-0.037 pp)·stock down 3.4% in the 30 days before

Jun 22·entry $73.56·now $92.44

+25.67%

since Jun 22

AIVL · Weight decrease · 4d

stock up 0.9% in the 30 days before

Jun 18·entry $75.43·now $92.44

+22.55%

since Jun 18

AIVL · Weight decrease · 3d

stock up 3.1% in the 30 days before

Jun 16·entry $76.56·now $92.44

+20.74%

since Jun 16

AIVL · Weight decrease · 2d

stock up 6.0% in the 30 days before

Jun 12·entry $78.87·now $92.44

+17.21%

since Jun 12

AIVL · Weight increase · 2d

stock up 19.4% in the 30 days before

Jun 4·entry $82.42·now $92.44Chased

+12.16%

since Jun 4

AIVL · Accumulation · 5d

stock up 7.8% in the 30 days before

May 15·entry $74.26·now $92.44Chased

+24.48%

since May 15

AIVL · Accumulation · 5d

stock up 7.7% in the 30 days before

May 14·entry $74.42·now $92.44Chased

+24.21%

since May 14

AIVL · Accumulation · 6d

stock up 7.8% in the 30 days before

May 13·entry $74.41·now $92.44Chased

+24.23%

since May 13

AIVL · Accumulation · 7d

stock up 11.4% in the 30 days before

May 12·entry $75.10·now $92.44Chased

+23.09%

since May 12

AIVL · Accumulation · 6d

stock up 12.7% in the 30 days before

May 11·entry $74.12·now $92.44Chased

+24.72%

since May 11

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Aug 23

The AI ETFs, particularly AIVL, show a clear trend of gradual accumulation and increasing weight in SOLVENTUM, suggesting an algorithmic positive signal. This contrasts with the framework's 'Fail' verdict, which is based on an inability to sufficiently assess critical long-term investment criteria such as management quality, consistent financial health, and a quantifiable margin of safety due to data limitations.

Circle of CompetenceThe company's position in Health Care Technology, as an established spin-off, suggests its unit economics for core products are likely stable enough to project future cash flows, assuming its operations are within mature segments of the industry.
Economic MoatAs a significant player in Health Care Technology, the company likely benefits from enduring competitive advantages such as regulatory barriers, intellectual property, and switching costs within established medical systems.
ManagementThe provided financial data is insufficient to assess management's candor, capital allocation discipline, or their personal stake in the company, which are critical components of the framework.
Financial HealthWhile the reported ROE of 28.98% is strong, there is a lack of historical data on 10-year average ROE, stable operating margins, manageable debt levels, and owner earnings to confidently pass this financial health stage.
Margin of SafetyDespite a seemingly low P/E ratio of 10.26, the absence of comprehensive financial and qualitative data prevents a defensible calculation of intrinsic value and thus a conclusive margin of safety.

While SOLVENTUM operates in an industry that could offer predictable unit economics and moats, the absence of detailed information on management's track record, historical financial performance consistency, and a clear margin of safety makes it impossible to classify as a 'Pass' within this value investing framework. The framework's stringent requirements for transparency and predictability were not met by the available data, leading to a 'Fail' verdict.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.